Accessibility Menu
GH Research logo

GH Research

(NASDAQ) GHRS

Current Price$28.06
Market Cap$1.74B
Since IPO (2021)+32%
5 Year+32%
1 Year+113%
1 Month+9%

GH Research Financials at a Glance

Market Cap

$1.74B

Revenue (TTM)

$0.00

Net Income (TTM)

-$56.41M

EPS (TTM)

-$0.91

P/E Ratio

-27.86

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$28.06

Volume

275,620

Open

$25.08

Previous Close

$28.22

Daily Range

$25.08 - $28.32

52-Week Range

$11.32 - $28.32

Estimated Earnings Date

Aug 6, 2026

GHRS News

GHRS: Motley Fool Moneyball Superscore

51

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About GH Research

Industry

Pharmaceuticals

Employees

73

CEO

Villy Valcheva, MD

Headquarters

Dublin, D02 NX43, IE

GHRS Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-19.83%

Return on Capital

-21.65%

Return on Assets

-20.49%

Earnings Yield

-3.59%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.74B

Shares Outstanding

68.56M

Volume

275.62K

Avg. Volume

245.14K

Financials (TTM)

Gross Profit

-$268.00K

Operating Income

-$66.69M

EBITDA

-$55.86M

Operating Cash Flow

-$46.33M

Capital Expenditure

-$181.36K

Free Cash Flow

-$46.51M

Cash & ST Invst.

$267.33M

Total Debt

$432.00K

GH Research Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$91.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$1.74B

N/A

Market Cap/Employee

$34.74M

N/A

Employees

50

N/A

Net Income

-$18.97M

-75.4%

EBITDA

-$18.79M

-75.2%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$267.33M

-8.2%

Total Debt

$432.00K

-34.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$75.00K

-76.7%

Short Term Debt

$357.00K

+6.3%

Return on Assets

-20.49%

N/A

Return on Invested Capital

-25.31%

N/A

Free Cash Flow

-$10.73M

-25.1%

Operating Cash Flow

-$10.67M

-24.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PVLAPalvella Therapeutics, Inc.
$148.21+8.82%
NBTXNanobiotix S.A.
$35.99+4.53%
TYRATyra Biosciences, Inc.
$31.88+3.04%
SVRASavara Inc.
$5.90-2.16%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$17.87+0.02%
ONDSOndas
$7.83+0.02%
KEELKeel Infrastructure
$6.03+0.03%
SOFISoFi Technologies
$17.88+0.03%

Questions About GHRS

What is the current price of GH Research?

GH Research is trading at $28.22 per share.

What is the 52-week range for GH Research?

Over the past 52 weeks, GH Research has traded between $11.32 and $28.32.

How much debt does GH Research have?

As of the most recent reporting period, GH Research reported total debt of $432.00K.

How much cash does GH Research have on hand?

GH Research reported $242.65M in cash and cash equivalents in its most recent financial results.

What is GH Research’s dividend yield?

GH Research does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.